Neurotech International Ltd - Asset Resilience Ratio

Latest as of December 2025: 0.22%

Neurotech International Ltd (NTI) has an Asset Resilience Ratio of 0.22% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Neurotech International Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

AU$15.00K

≈ $10.61K USD Cash + Short-term Investments

Total Assets

AU$6.81 Million

≈ $4.82 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Neurotech International Ltd's Asset Resilience Ratio has changed over time. See NTI net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Neurotech International Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Neurotech International Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$15.00K	0.22%
Total Liquid Assets	AU$15.00K	0.22%

Asset Resilience Insights

Limited Liquidity: Neurotech International Ltd maintains only 0.22% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Neurotech International Ltd Industry Peers by Asset Resilience Ratio

Compare Neurotech International Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Ascendis Pharma AS F:A71	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	1.39%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shanghai Shen Lian Biomedical Corp SHG:688098	Biotechnology	3.87%

Annual Asset Resilience Ratio for Neurotech International Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Neurotech International Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	0.46%	AU$15.00K ≈ $10.61K	AU$3.24 Million ≈ $2.29 Million	-77.44pp
2024-06-30	77.91%	AU$9.52 Million ≈ $6.73 Million	AU$12.21 Million ≈ $8.64 Million	+39.95pp
2023-06-30	37.96%	AU$2.02 Million ≈ $1.43 Million	AU$5.31 Million ≈ $3.76 Million	+37.21pp
2022-06-30	0.74%	AU$15.00K ≈ $10.61K	AU$2.02 Million ≈ $1.43 Million	-95.69pp
2021-06-30	96.43%	AU$4.83 Million ≈ $3.42 Million	AU$5.01 Million ≈ $3.54 Million	+48.40pp
2018-06-30	48.03%	AU$2.21 Million ≈ $1.57 Million	AU$4.61 Million ≈ $3.26 Million	+3.50pp
2017-06-30	44.53%	AU$2.21 Million ≈ $1.56 Million	AU$4.95 Million ≈ $3.50 Million	+41.28pp
2016-06-30	3.25%	AU$500.00K ≈ $353.78K	AU$15.37 Million ≈ $10.88 Million	--

pp = percentage points

About Neurotech International Ltd

AU:NTI Australia Biotechnology

Market Cap

$11.01 Million

AU$15.56 Million AUD

Market Cap Rank

#26629 Global

#1305 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.03

All Time High

AU$0.48